Finance
French biotech company Ipsen to buy Kartos Therapeutics for $450 million
June 29 (Reuters) - Ipsen will buy U.S.-based Kartos Therapeutics for $450 million to expand its onc...
29th June, 2026
June 29 (Reuters) - Ipsen will buy U.S.-based Kartos Therapeutics for $450 million to expand its onc...
29th June, 2026
By Bhanvi Satija LONDON, April 12 (Reuters) - British drugmaker GSK's experimental targeted cancer d...
12th April, 2026